The global metagenomics market is defined as the industry that develops, applies, and commercializes technologies and tools to analyze the genetic material (DNA/RNA) present in environmental samples, including soil, water, air, and human microbiomes, without culturing organisms in a laboratory. Continuous technological advancements, particularly in sequencing technologies with the advent of next-generation sequencing (NGS), which has been made more efficient, accurate, and cost-effective are one of the major drivers. Explorations into human, animal, and environmental microbiomes have created an increased demand for metagenomic research in understanding microbial communities' influence on health, immunity, and disease prevention.